くすりのしおり

Injection
Published: 12/2018

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
ATROPINE SULFATE Injection 0.5mg "TANABE"
 Active ingredient:
Atropine sulfate hydrate
 Dosage form:
injection
 Print on wrapping:

Effects of this medicine

This medicine relieves gastrointestinal tension and suppresses the motility. It also works on myocardium and increases heart rate. Furthermore, it inhibits secretion of saliva, bronchial mucosa, gastric juice, and pancreatic juice etc.
It is usually used for hyper secretion and hyperactivity in gastroduodenal ulcer, gastrointestinal spasmodic pain, spastic constipation, bile duct or ureteral pain, detoxification for organophosphorus insecticides and parasympathomimetic agents, vagal bradycardia and vagus nerve atrioventricular conduction disorder, other bradycardia and atrioventricular conduction disorder, pre-anesthetic medication, and pre-treatment for ECT (electroconvulsive therapy).

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
  • If you have glaucoma, dysuria due to prostatic hypertrophy, or paralytic ileus.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • In general, for adults, this medicine is injected subcutaneously, intramuscularly or intravenously. For organophosphorus insecticide poisoning, it is injected subcutaneously or taken orally in mild case, however, it is injected subcutaneously, intramuscularly or intravenously in moderate to severe case.
  • Treatment duration will be determined depending on the symptoms.

Precautions while taking this medicine

  • This medicine may cause blurred vision and pupil dilation. Avoid driving a car or operating dangerous machinery after injection.

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include mydriasis, vision adjustment disorder, thirst, nausea, vomiting, swallowing disorder, constipation, urination disorder, headache, dull headache, disturbance of memorization, palpitation, breathing disorder, rash, and facial flushing. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • tachycardia, generalized flushing, sweating, facial edema [shock, anaphylactoid symptoms]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.

Keywords Search

 

 

 

 

Advanced Search

Browse by drug name A-Z
Browse by drug name A-Z